Overall, cancer vaccines are unlikely to become universal stand-alone treatments for advanced solid tumors, and their most credible role may emerge in molecularly selected patients, adjuvant therapy, minimal residual disease, virus-associated malignancies, and rational combinations with checkpoint inhibitors or tumor microenvironment-modulating agents.
Dario Rusciano· Frontiers in Cell and Develo...· 0 citations
The mitochondrial, redox, inflammatory, and neurovascular mechanisms proposed for PBM are examined, and preclinical and clinical evidence across nonexudative AMD, inherited retinal degeneration, diabetic retinal disease, and light-induced damage is discussed.
M. Toro, Alessandro Avitabile, Roberta Amato et al.· Antioxidants· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.